— The pharmaceutical company soared more than 10% after Cantor Fitzgerald reiterated an overweight rating on the stock. The firm said it sees sales of TG Therapeutics' treatment for relapsing forms of multiple sclerosis, Briumvi, to come in above expectations for the second quarter.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Levi Strauss stock falls 5% after outlook is cutLevi Strauss & Co. shares fell in the extended session Thursday after the jeans company cut its forecast for the year while topping the Wall Street earnings...
Source: MarketWatch - 🏆 3. / 97 Read more »
Levi Strauss shares tumble on outlook cut, Mallinckrodt and Alibaba shares rise and more stocks on the moveMallinckrodt, Levi Strauss, Alibaba, Costco and EV makers Nikola and XPeng were all on the move ahead of Friday's market open.
Source: MarketWatch - 🏆 3. / 97 Read more »
Amazon-Rivian deal sends shares to new highRivian shares hit a new high after Amazon announced it was taking the auto company’s technology to Europe with first rollouts in Munich, Berlin and Düsseldorf, Germany.
Source: FoxBusiness - 🏆 458. / 53 Read more »